Growth Metrics

Outlook Therapeutics (OTLK) Minority Interest: 2015

Historic Minority Interest for Outlook Therapeutics (OTLK) over the last 1 years, with Sep 2015 value amounting to $27.3 million.

  • Outlook Therapeutics' Minority Interest was N/A to $17.4 million in Q1 2016 from the same period last year, while for Mar 2016 it was $17.4 million, marking a year-over-year change of. This contributed to the annual value of $27.3 million for FY2015, which is N/A change from last year.
  • Outlook Therapeutics' Minority Interest amounted to $27.3 million in FY2015.
  • Over the past 5 years, Outlook Therapeutics' Minority Interest peaked at $27.3 million during FY2015, and registered a low of $27.3 million during FY2015.
  • In the last 1 years, Outlook Therapeutics' Minority Interest had a median value of $27.3 million in 2015 and averaged $27.3 million.